⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
AGARWALEYE - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 2.7
| Stock Code | AGARWALEYE | Market Cap | 13,955 Cr. | Current Price | 440 ₹ | High / Low | 568 ₹ |
| Stock P/E | 266 | Book Value | 61.8 ₹ | Dividend Yield | 0.00 % | ROCE | 5.94 % |
| ROE | 1.31 % | Face Value | 1.00 ₹ | DMA 50 | 485 ₹ | DMA 200 | 464 ₹ |
| Chg in FII Hold | -0.07 % | Chg in DII Hold | -0.14 % | PAT Qtr | 4.95 Cr. | PAT Prev Qtr | 10.4 Cr. |
| RSI | 33.0 | MACD | -17.8 | Volume | 4,04,933 | Avg Vol 1Wk | 4,12,822 |
| Low price | 327 ₹ | High price | 568 ₹ | PEG Ratio | 1.75 | Debt to equity | 0.30 |
| 52w Index | 47.1 % | Qtr Profit Var | 512 % | EPS | 1.55 ₹ | Industry PE | 45.1 |
📊 Technical Analysis
- Chart Patterns: Stock has corrected from 568 ₹ high to 440 ₹, showing a bearish trend.
- Moving Averages: Current price is below both 50 DMA (485 ₹) and 200 DMA (464 ₹), confirming weakness.
- RSI: 33.0 — near oversold zone, potential for short-term bounce.
- MACD: -17.8 — bearish crossover, momentum weak.
- Bollinger Bands: Price near lower band, oversold conditions visible.
- Volume Trends: Current volume (4.04L) is slightly below 1-week average (4.12L), showing reduced participation.
📈 Momentum & Signals
- Short-term Momentum: Weak, but oversold RSI suggests possible relief rally.
- Support Levels: Strong support near 327 ₹.
- Resistance Levels: Immediate resistance at 464–485 ₹ (DMA zone).
- Optimal Entry Zone: 430–445 ₹ (near support).
- Optimal Exit Zone: 470–490 ₹ (near resistance).
- Trend Status: Stock is trending down with oversold signals suggesting possible short-term reversal.
✅ Positive
- PEG ratio of 1.75 indicates fair valuation relative to growth.
- EPS of 1.55 ₹ provides earnings visibility.
- Quarterly profit variation (+512%) shows strong rebound compared to prior weak quarter.
⚠️ Limitation
- Stock P/E (266) is extremely high compared to industry P/E (45.1), suggesting overvaluation.
- ROCE (5.94%) and ROE (1.31%) are weak, reflecting poor efficiency.
- Debt-to-equity ratio (0.30) is moderate, adding financial risk.
📉 Company Negative News
- Quarterly PAT declined sharply (4.95 Cr vs 10.4 Cr).
- FII holding decreased by -0.07% and DII holding decreased by -0.14%, showing reduced institutional confidence.
- Stock has corrected significantly from 568 ₹ high to current 440 ₹.
📈 Company Positive News
- Quarterly profit variation (+512%) highlights strong rebound from prior weak quarter.
- Stock remains above 52-week low (327 ₹), showing resilience despite correction.
🏭 Industry
- Industry P/E at 45.1 is much lower than AGARWALEYE, highlighting relative overvaluation.
- Healthcare and diagnostics sector remains growth-oriented, supported by rising demand for eye care services.
📝 Conclusion
- AGARWALEYE is in a downtrend with weak fundamentals and high valuation.
- Best strategy: Accumulate cautiously near support (430–445 ₹) and book profits near resistance (470–490 ₹).
- Short-term traders may benefit from oversold bounce, but long-term investors should be cautious given high P/E and modest efficiency.